Cambre Kelly
Principal investigator, leads RESELUTE, INC. and RESTOR3D, Inc..
MedtechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2022First federal award
$1.3MFederal grants as PI2 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
2 awards · $1.3M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 15, 2024 | NSF | STTR Phase II STTR Phase II: Development of a Antibiotic Releasing Intramedullary Nail for Treatment of Fracture Related Infections | $999K | RESELUTE, INC. |
| Feb 5, 2022 | NSF | SBIR Phase I SBIR Phase I: Localized and Sustained Antibiotic Delivery For Treatment of Periprosthetic Joint Infection (PJI) in Arthroplasty Patients | $275K | RESELUTE, INC. |
1 patents as inventor
- US RESELUTE, INC.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#1,829
Awards as PI#1,503
Patents#505
Companies
- RESELUTE, INC.Leads (SEC Form D) · Medtech
- RESTOR3D, Inc.Leads (SEC Form D) · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.